Literature DB >> 8943047

Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

J L Cook1, C K Krantz, B A Routes.   

Abstract

The mechanism by which the adenoviral (Ad) E1A oncogene induces cellular susceptibility to lysis by killer lymphocytes involves interactions between its first exon and different second-exon accessory regions. Mutational analysis showed that two first-exon regions--one in the N terminus and one in the conserved region 1 (CR1) domain--are necessary for this activity. E1A complex formation with cellular p300 protein through these first-exon-encoded regions correlated with induction of the cytolytic susceptible phenotype but was only effective in the context of E1A second-exon expression. An E1A first-exon deletion that prevented p300 binding eliminated both oncoprotein-induced cytolytic susceptibility and rejection of transfected sarcoma cells by immunocompetent animals. These results suggest that the E1A oncogene induces cytolytic susceptibility and tumor rejection by interactions with cellular proteins of the p300 family that affect transcription of genes involved in the cellular response to injury inflicted by host killer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943047      PMCID: PMC19481          DOI: 10.1073/pnas.93.24.13985

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Association of adenovirus early-region 1A proteins with cellular polypeptides.

Authors:  E Harlow; P Whyte; B R Franza; C Schley
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides.

Authors:  S P Yee; P E Branton
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

3.  Adenovirus E1a ras cooperation activity is separate from its positive and negative transcription regulatory functions.

Authors:  A Velcich; E Ziff
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

4.  E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity.

Authors:  H G Wang; E Moran; P Yaciuk
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.

Authors:  J L Cook; B A Wilson; L A Wolf; T A Walker
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

6.  Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.

Authors:  A R Fattaey; E Harlow; K Helin
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses.

Authors:  H van Ormondt; J Maat; R Dijkema
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

8.  Immortalization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S.

Authors:  M P Quinlan; J L Douglas
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Repression of transforming growth factor beta 1 promoter by the adenovirus oncogene E1A. Identification of a unique GC-rich sequence as a target for E1A repression.

Authors:  P K Datta; S Bagchi
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

10.  Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells.

Authors:  J L Cook; D L May; A M Lewis; T A Walker
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

View more
  7 in total

1.  Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.

Authors:  Tanya A Miura; Han Li; Kristin Morris; Sharon Ryan; Kristine Hembre; James L Cook; John M Routes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

3.  Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.

Authors:  John M Routes; Kristin Morris; Misoo C Ellison; Sharon Ryan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

Authors:  James L Cook; Thomas A Walker; G Scott Worthen; Jay R Radke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

5.  Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.

Authors:  John M Routes; Sharon Ryan; Kristin Morris; Rayna Takaki; Adelheid Cerwenka; Lewis L Lanier
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

6.  Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D.

Authors:  Michael J Korrer; John M Routes
Journal:  Results Immunol       Date:  2015-01-15

7.  Possible role of arginase-1 in concomitant tumor immunity.

Authors:  Michael J Korrer; Yuwen Zhang; John M Routes
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.